We are live on ! Find out more
Arrowstreet Capital

Arrowstreet Capital Portfolio holdings

AUM $185B
1-Year Est. Return 39.58%
This Fund
S&P 500
This Quarter Est. Return
+1.19%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$17.7B
AUM Growth
+$1.44B
Cap. Flow
+$1.58B
Cap. Flow %
8.95%
Top 10 Hldgs %
19.92%
Holding
1,403
New
439
Increased
358
Reduced
346
Closed
241

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$403M
2
DIS icon
Walt Disney
DIS
+$157M
3
CELG
Celgene Corp
CELG
+$141M
4
C icon
Citigroup
C
+$137M
5
SBUX icon
Starbucks
SBUX
+$132M

Sector Composition

Rank Sector Weight
1 Technology 24.11%
2 Financials 17.79%
3 Healthcare 17.78%
4 Consumer Staples 7.98%
5 Consumer Discretionary 7.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTRI
451
DELISTED
NutriSystem, Inc.
NTRI
$4.56M 0.03%
183,239
+49,051
+37% +$1.1M
FSP
452
Franklin Street Properties
FSP
$46.8M
$4.55M 0.03%
402,636
-245,445
-38% -$2.93M
TSE
453
DELISTED
Trinseo
TSE
$4.55M 0.03%
+169,371
New +$4.33M
FMS icon
454
Fresenius Medical Care
FMS
$12.9B
$4.54M 0.03%
109,040
+89,140
+448% +$3.81M
BAH icon
455
Booz Allen Hamilton
BAH
$9.15B
$4.53M 0.03%
179,573
-61,351
-25% -$1.66M
GGG icon
456
Graco
GGG
$13.5B
$4.53M 0.03%
191,400
+75,300
+65% +$1.82M
EOCC
457
DELISTED
Enel Generacion Chile S.A.
EOCC
$4.52M 0.03%
+157,593
New +$4.93M
SYKE
458
DELISTED
SYKES Enterprises Inc
SYKE
$4.45M 0.03%
183,355
-13,084
-7% -$323K
APTV icon
459
Aptiv
APTV
$10.3B
$4.44M 0.03%
+52,200
New +$4.47M
CAH icon
460
Cardinal Health
CAH
$55.4B
$4.42M 0.03%
52,900
+16,828
+47% +$1.49M
ADT
461
DELISTED
ADT Corp
ADT
$4.42M 0.03%
131,662
-577,695
-81% -$22M
VISN
462
Vistance Networks Inc
VISN
$2.52B
$4.42M 0.03%
144,756
+105,356
+267% +$3.2M
MIDD icon
463
Middleby
MIDD
$6.08B
$4.39M 0.02%
39,100
+23,100
+144% +$2.47M
ATW
464
DELISTED
Atwood Oceanics
ATW
$4.38M 0.02%
+165,646
New +$5.09M
TWX
465
DELISTED
Time Warner Inc
TWX
$4.36M 0.02%
49,891
-855
-2% -$73K
BHE icon
466
Benchmark Electronics
BHE
$2.96B
$4.31M 0.02%
197,794
-123,184
-38% -$2.92M
BCR
467
DELISTED
CR Bard Inc.
BCR
$4.26M 0.02%
24,962
+21,762
+680% +$3.72M
OA
468
DELISTED
Orbital ATK, Inc.
OA
$4.25M 0.02%
+58,000
New +$4.36M
EWBC icon
469
East-West Bancorp
EWBC
$18B
$4.25M 0.02%
+94,800
New +$4.06M
GGB icon
470
Gerdau
GGB
$9.7B
$4.22M 0.02%
2,208,780
+2,119,950
+2,387% +$5.11M
ADEA icon
471
Adeia
ADEA
$3.11B
$4.21M 0.02%
419,440
+236,038
+129% +$2.42M
PGR icon
472
Progressive
PGR
$125B
$4.2M 0.02%
151,026
-504,352
-77% -$13.8M
MASI
473
DELISTED
Masimo
MASI
$4.18M 0.02%
+107,962
New +$3.87M
ISLE
474
DELISTED
Isle of Capri Casinos Inc
ISLE
$4.17M 0.02%
229,844
+145,619
+173% +$2.28M
PRI icon
475
Primerica
PRI
$9.89B
$4.15M 0.02%
+90,900
New +$4.25M

Similar funds

Arrowstreet Capital's Q2 2015 Portfolio in Review

As of Q2 2015, Arrowstreet Capital held 1,403 positions worth $17.7B, up 8.9% from $16.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Arrowstreet Capital deployed $1.58B of net new capital in Q2 2015, opening 439 new positions and adding to 358 existing holdings. Its largest new stake was Teva Pharmaceuticals: 1,922,584 shares worth $114M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 29% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Union Pacific, an estimated $244M trimmed.

  • Arrowstreet Capital's largest Q2 2015 buy was Teva Pharmaceuticals: 1,922,584 shares worth $114M.
  • Arrowstreet Capital added most to Apple in Q2 2015, an estimated $403M increase.
  • Arrowstreet Capital's biggest Q2 2015 reduction was Union Pacific, cutting an estimated $244M.
  • Arrowstreet Capital fully exited Canadian National Railway in Q2 2015, selling an estimated $146M.
  • Arrowstreet Capital's ten largest holdings make up 20% of its $17.7B portfolio in Q2 2015.
  • Arrowstreet Capital opened 439 new positions and closed 241 in Q2 2015.
  • Arrowstreet Capital's portfolio value rose 8.9% quarter-over-quarter to $17.7B.

Based on Arrowstreet Capital's 13F filing for Q2 2015, filed 13 Aug 2015.